Clinical Trials in Phoenix

Showing 8741-8760 of 16,646 trials

Advanced Biomarker Assessment in Pelvic Organ Prolapse

NCT03642054

This study will assess advanced biomarkers in patients with and without vaginal prolapse. Assessments will be directed at vaginal fibroblasts and adipose derived stem cells.

Pelvic Organ Prolapse

Mayo Clinic18 participantsStarted Jun 2018

Phoenix, Arizona, United States

COMPLETEDNA< 1 mile

Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas

NCT04006236

This is a randomized, controlled, double-blind, multicenter parallel study to evaluate the growth, tolerance and compliance of healthy infants fed infant formulas with extensively hydrolyzed casein protein.

Infant Development

Abbott Nutrition245 participantsStarted Aug 2019

Phoenix, Arizona, United States • Tucson, Arizona, United States • College Park, Georgia, United States +14 more locations

Advanced Biomarker Assessment in Pelvic Organ Prolapse

Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas

Find Trials by Condition in Phoenix

Barrow Ruptured Aneurysm Trial

An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension

A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer

Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma

A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors

Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)

Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects

Dose Range Study of CD5789 in Acne Vulgaris

Evaluation of Subchondroplasty™ for Defects Associated With Bone Marrow Lesions

A Phase 1/2, Open-label, Dose Finding Study to Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer

A Study of Alectinib in RET-rearranged Non-small Cell Lung Cancer or RET-mutated Thyroid Cancer

OptiMesh® for Lumbar Interbody Fusion Trial (OLIF)

Assessing Symptomatic Clinical Episodes in Depression

Stress Management for Cancer Patients: How Well Does it Work? (C2H-D)

Panitumumab IRDye800 Optical Imaging Study

A Cohort Study of Operationally Tolerant Allograft Recipients

Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Low Dose Study)